New Biologics Manufacturing Facility To Be Built In Singapore

Dec. 7, 2006
Another boost to commercial biopharmaceutical manufacturing.

Singapore's second commercial biopharmaceutical manufacturing plant will be built by Swiss-based Lonza Group and Singapore's Bio*One Capital. The $350 million large-scale mammalian cell culture plant -- the second in Singapore for commercial biopharmaceuticals manufacturing -- will be completed in 2011.

"The facility will operate with cutting edge technology with a skilled labor force and will be able to manufacture products with a wide array of processes, yields and technologies," said Stefan Borgas, CEO of Lonza.

In February 2006, Lonza and Bio*One entered into an initial joint venture to build Singapore's first commercial-scale biologics manufacturing facility, an 80,000 liter large-scale mammalian biopharmaceutical production facility named Lonza Biologics Singapore Pte Ltd.

The second plant is expected to be constructed over two phases with the Lonza Biologics Tuas shell becoming operational in March 2007 and final build-out completed in 2011. The plant will have a staff of 350.

Singapore's biomedical sciences industry grew 23% in manufacturing output last year.

Interested in information related to this topic? Subscribe to our weekly Value-chain eNewsletter.

Popular Sponsored Recommendations

Navigating Disruption: A Leader’s Guide to Strategy Under Uncertainty

Nov. 1, 2023
AI, sustainability, digital--industrials are facing disruptive forces that are redefining what it takes to win. What got your company where it is today won’t get you where you...

Discover How an Eye Tracking Study Improves Training Procedures

Oct. 29, 2023
Did you know that your training processes can be streamlined by visualizing and analyzing key skills within your employee base? Find out how we use eye tracking to capture advanced...

7 Crucial Steps to Improve Your OT Security

Oct. 23, 2023
Enhance OT security in manufacturing and production. Uncover the crucial steps to safeguard your operational technology. Protect against evolving threats and bridge the IT-OT ...

Discrete and Process Manufacturing 2024 Trends and Outlook for North America

Oct. 29, 2023
Manufacturers are reaping the benefits of automation and cloud-based solutions. Discover what is driving today's industry trends and how they can shape your growth priorities ...

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!